Orris

Why does metabolic syndromes happen, tell me diagnostic features of dyslipdemia,what is pathophysiology or reason for dyslipdemia, primary, secondary and tertiary prevention of dyslipdemia i.e metabolic syndrome in brief

Reading File
Reading File
Finding Sources
Finding Sources
Searching PubMed

"metabolic syndrome" AND dyslipidemia

Searching the Web

metabolic syndrome diagnostic criteria dyslipidemia prevention primary secondary tertiary guideline

Finding Sources
Finding Sources
Finding Sources

Quick answer

Metabolic syndrome: why it happens

Metabolic syndrome is a cluster of risk factors caused mainly by central obesity and insulin resistance. It increases the risk of type 2 diabetes, fatty liver disease, atherosclerotic cardiovascular disease, stroke, and chronic kidney disease.

Main mechanism

  1. Excess visceral abdominal fat releases more free fatty acids and inflammatory substances.
  2. These free fatty acids reach the liver and promote:
    • Increased triglyceride production
    • Increased VLDL production
    • Fat accumulation in the liver
  3. Insulin resistance develops in muscle, liver, and adipose tissue:
    • Muscle takes up less glucose
    • Liver continues producing glucose
    • Blood glucose rises
    • Insulin levels rise initially
  4. Insulin resistance and excess fatty-acid delivery cause the typical lipid pattern:
    • High triglycerides
    • Low HDL cholesterol
    • Small, dense LDL particles, which are particularly atherogenic
  5. Inflammation, endothelial dysfunction, sympathetic activation, and altered kidney sodium handling contribute to hypertension and vascular disease.

Diagnostic features

Metabolic syndrome

A commonly used harmonized definition diagnoses metabolic syndrome when any 3 of these 5 are present:
FeatureCut-off
Central obesityWaist circumference, population/ethnicity-specific cut-off
Raised triglycerides≥150 mg/dL or on treatment
Low HDL cholesterol<40 mg/dL in men, <50 mg/dL in women, or on treatment
Raised blood pressure≥130/85 mmHg or on antihypertensive treatment
Raised fasting glucose≥100 mg/dL or diabetes treatment

Dyslipidemia

Dyslipidemia means an abnormal lipid profile. It may include:
  • Raised LDL cholesterol
  • Raised total cholesterol
  • Raised triglycerides
  • Low HDL cholesterol
  • Raised non-HDL cholesterol or apoB
  • In metabolic syndrome: high triglycerides, low HDL, increased VLDL/remnant particles, and small dense LDL.
A lipid profile measures total cholesterol, LDL-C, HDL-C, and triglycerides. Testing during an acute infection or other inflammatory illness can temporarily raise triglycerides and lower LDL-C, so repeat testing after recovery may be needed. Fischer's Mastery of Surgery - 8th e, lines 3984-3996.

Pathophysiology of dyslipidemia in metabolic syndrome

The typical sequence is:
Central obesity → insulin resistance → increased free fatty acids to liver → increased hepatic VLDL-triglyceride production
Then:
  • Lipoprotein lipase activity and clearance of triglyceride-rich particles are reduced.
  • ApoC-III can inhibit lipoprotein lipase, slowing removal of VLDL remnants.
  • Cholesteryl ester transfer protein exchanges triglycerides into HDL and LDL.
  • Triglyceride-rich HDL is cleared more rapidly, causing low HDL-C.
  • LDL becomes smaller and denser, making it more likely to enter arterial walls and promote atherosclerosis.
This is called atherogenic dyslipidemia.

Causes of dyslipidemia

1. Primary dyslipidemia

These are inherited/genetic disorders of lipid metabolism. Examples:
  • Familial hypercholesterolemia: defective or reduced LDL-receptor function
  • Familial combined hyperlipidemia
  • Familial hypertriglyceridemia
  • Lipoprotein lipase deficiency
  • ApoC-II deficiency
  • Disorders of cholesterol or lipoprotein breakdown
Suspect a primary cause with very high lipid levels, tendon xanthomas, xanthelasma, strong family history, or premature coronary artery disease. Genetic mechanisms can include decreased LDL receptors, reduced lipoprotein lipase function, lipase inhibitors, or enzyme defects. Fischer's Mastery of Surgery - 8th e, lines 3984-3989.

2. Secondary dyslipidemia

These are acquired and more common. Causes include:
  • Overweight/central obesity and physical inactivity
  • Diet high in refined carbohydrates, saturated fats, trans fats, or excess calories
  • Excess alcohol, especially with high triglycerides
  • Type 2 diabetes and insulin resistance
  • Hypothyroidism
  • Chronic kidney disease or nephrotic syndrome
  • Cholestatic liver disease
  • Cushing syndrome
  • Pregnancy
  • Polycystic ovary syndrome
  • Drugs: corticosteroids, thiazides, some beta-blockers, retinoids such as isotretinoin, antiretroviral medicines, atypical antipsychotics, cyclosporine, and some immunosuppressants.
The medical text specifically lists diet, alcohol, lifestyle, diseases, and medicines including steroids, isotretinoin, beta-blockers, and antiretrovirals as secondary influences. Tietz Textbook of Laboratory Medicine, “Primary versus Secondary Dyslipoproteinemias.”

Prevention of dyslipidemia and metabolic syndrome

Primary prevention: prevent disease before it develops

For people without established dyslipidemia, diabetes, or cardiovascular disease:
  • Maintain healthy body weight and waist circumference.
  • Exercise regularly: at least 150 minutes/week of moderate aerobic activity plus muscle-strengthening exercise.
  • Eat a dietary pattern rich in vegetables, fruits, whole grains, legumes, nuts, and unsaturated fats.
  • Reduce refined carbohydrates, sugary drinks, processed foods, trans fats, and excess saturated fat.
  • Avoid smoking and tobacco.
  • Limit or avoid alcohol, especially if triglycerides are elevated.
  • Sleep adequately and manage stress.
  • Screen blood pressure, glucose/HbA1c, waist circumference, and lipids in people with obesity, family history, diabetes risk, hypertension, or smoking.

Secondary prevention: early detection and early treatment

For people with dyslipidemia, prediabetes, metabolic syndrome, or high cardiovascular risk but no established cardiovascular event:
  • Check fasting or nonfasting lipid profile, glucose/HbA1c, blood pressure, BMI, and waist circumference.
  • Identify and treat secondary causes, such as hypothyroidism, diabetes, renal disease, alcohol excess, or medication effects.
  • Intensive lifestyle intervention and weight loss.
  • Use lipid-lowering medicines when indicated by LDL level and overall ASCVD risk, most often a statin.
  • Control hypertension and prediabetes/diabetes.
  • Treat severe hypertriglyceridemia promptly to lower pancreatitis risk.

Tertiary prevention: prevent complications and disability

For people who already have coronary artery disease, stroke, peripheral arterial disease, diabetes complications, or pancreatitis:
  • Intensive lipid lowering, usually high-intensity or maximally tolerated statin therapy.
  • Add ezetimibe or other agents when needed to achieve risk-based LDL-C goals.
  • Strict blood pressure and diabetes control.
  • Smoking cessation, cardiac rehabilitation, supervised exercise, and dietary support.
  • Antiplatelet therapy or other vascular medicines only when clinically indicated.
  • Treat very high triglycerides and prevent recurrent pancreatitis.
  • Monitor for kidney disease, fatty liver disease, diabetic complications, and recurrent cardiovascular events.
Key point: Dyslipidemia is one component of metabolic syndrome, not the same thing. Metabolic syndrome is diagnosed from the broader combination of abdominal obesity, high triglycerides, low HDL, raised blood pressure, and raised glucose.
This is a shared conversation. Sign in to Orris to start your own chat.